SCD and fatty liver disease: Several studies have confirmed that SCD1 promoted both steatosis and hypertriglyceridemia, and inhibition of SCD1 expression was extremely effective in preventing diet-induced obesity, hepatic steatosis, and insulin resistance [31,36,37].